Clinical considerations for the diagnosis of idiopathic hypersomnia

Ohayon, 2008, From wakefulness to excessive sleepiness: what we know and still need to know, Sleep Med Rev, 12, 129, 10.1016/j.smrv.2008.01.001 2014 Lammers, 2020, Diagnosis of central disorders of hypersomnolence: a reappraisal by European experts, Sleep Med Rev, 52, 10.1016/j.smrv.2020.101306 Jaussent, 2017, Incidence, worsening and risk factors of daytime sleepiness in a population-based 5-year longitudinal study, Sci Rep, 7, 1372, 10.1038/s41598-017-01547-0 Ohayon, 2012, Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology, Arch Gen Psychiatr, 69, 71, 10.1001/archgenpsychiatry.2011.1240 Fernandez-Mendoza, 2015, Natural history of excessive daytime sleepiness: role of obesity, weight loss, depression, and sleep propensity, Sleep, 38, 351, 10.5665/sleep.4488 Trotti, 2017, Idiopathic hypersomnia, Sleep Med Clin, 12, 331, 10.1016/j.jsmc.2017.03.009 Johns, 1992, Reliability and factor analysis of the Epworth sleepiness scale, Sleep, 15, 376, 10.1093/sleep/15.4.376 Krahn, 2021, Recommended protocols for the multiple sleep latency test and maintenance of wakefulness test in adults: guidance from the American Academy of Sleep Medicine, J Clin Sleep Med, 17, 2489, 10.5664/jcsm.9620 Ohayon, 2013, Excessive sleep duration and quality of life, Ann Neurol, 73, 785, 10.1002/ana.23818 Nevsimalova, 2021, Idiopathic hypersomnia: a homogeneous or heterogeneous disease?, Sleep Med, 80, 86, 10.1016/j.sleep.2021.01.031 Trotti, 2017, Waking up is the hardest thing I do all day: sleep inertia and sleep drunkenness, Sleep Med Rev, 35, 76, 10.1016/j.smrv.2016.08.005 Vernet, 2010, Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness, J Sleep Res, 19, 525, 10.1111/j.1365-2869.2010.00824.x Acquavella, 2020, Prevalence of narcolepsy, other sleep disorders, and diagnostic tests from 2013–2016: insured patients actively seeking care, J Clin Sleep Med, 16, 1255, 10.5664/jcsm.8482 Arnulf, 2019, Precision medicine for idiopathic hypersomnia, Sleep Med Clin, 14, 333, 10.1016/j.jsmc.2019.05.007 Billiard, 2016, Idiopathic hypersomnia, Sleep Med Rev, 29, 23, 10.1016/j.smrv.2015.08.007 Leu-Semenescu, 2016, Benefits and risk of sodium oxybate in idiopathic hypersomnia versus narcolepsy type 1: a chart review, Sleep Med, 17, 38, 10.1016/j.sleep.2015.10.005 Kretzschmar, 2016, Which diagnostic findings in disorders with excessive daytime sleepiness are really helpful? A retrospective study, J Sleep Res, 25, 307, 10.1111/jsr.12383 Trotti, 2020, Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registry, Sleep Med, 75, 343, 10.1016/j.sleep.2020.08.034 Vernet, 2009, Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients, Sleep, 32, 753, 10.1093/sleep/32.6.753 Evangelista, 2018, Alternative diagnostic criteria for idiopathic hypersomnia: a 32-hour protocol, Ann Neurol, 83, 235, 10.1002/ana.25141 Šonka, 2015, Narcolepsy with and without cataplexy, idiopathic hypersomnia with and without long sleep time: a cluster analysis, Sleep Med, 16, 225, 10.1016/j.sleep.2014.09.016 Roth, 1972, Hypersomnia with "sleep drunkenness, Arch Gen Psychiatr, 26, 456, 10.1001/archpsyc.1972.01750230066013 2001 2005, Idiopathic hypersomnia with long sleep time, 98 Pizza, 2019, Validation of multiple sleep latency test for the diagnosis of pediatric narcolepsy type 1, Neurology, 93, e1034, 10.1212/WNL.0000000000008094 Lopez, 2017, Test-retest reliability of the multiple sleep latency test in central disorders of hypersomnolence, Sleep, 40, zsx164, 10.1093/sleep/zsx164 Evangelista, 2021, Characteristics associated with hypersomnia and excessive daytime sleepiness identified by extended polysomnography recording, Sleep, 44, zsaa264, 10.1093/sleep/zsaa264 Kanady, 2015, Development and validation of the Sleep Inertia Questionnaire (SIQ) and assessment of sleep inertia in analogue and clinical depression, Cognit Ther Res, 39, 601, 10.1007/s10608-015-9686-4 Fernandez-Mendoza, 2021, The Hypersomnia Severity Index: reliability, construct, and criterion validity in a clinical sample of patients with sleep disorders, J Clin Sleep Med, 17, 2249, 10.5664/jcsm.9426 Evangelista, 2022, Sleep inertia measurement with the psychomotor vigilance task in idiopathic hypersomnia, Sleep, 45, zsab220, 10.1093/sleep/zsab220 Trotti, 2022, The Psychomotor Vigilance Test as a measure of alertness and sleep inertia in people with central disorders of hypersomnolence, J Clin Sleep Med, 18, 1395, 10.5664/jcsm.9884 Dauvilliers, 2019, Measurement of symptoms in idiopathic hypersomnia: the idiopathic hypersomnia severity scale, Neurology, 92, e1754, 10.1212/WNL.0000000000007264 Rassu, 2022, Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and their consequences in idiopathic hypersomnia, J Clin Sleep Med, 18, 617, 10.5664/jcsm.9682 Ohayon, 2000, Prevalence of hallucinations and their pathological associations in the general population, Psychiatr Res, 97, 153, 10.1016/S0165-1781(00)00227-4 Sharpless, 2011, Lifetime prevalence rates of sleep paralysis: a systematic review, Sleep Med Rev, 15, 311, 10.1016/j.smrv.2011.01.007 Chabani, 2020, Blackout of my nights: contentless, timeless and selfless report from the night in patients with central hypersomnias, Conscious Cognit, 81, 10.1016/j.concog.2020.102931 Trotti, 2013, Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia, J Clin Sleep Med, 9, 789, 10.5664/jcsm.2922 Ruoff, 2018, The MSLT is repeatable in narcolepsy type 1 but not narcolepsy type 2: a retrospective patient study, J Clin Sleep Med, 14, 65, 10.5664/jcsm.6882 Anderson, 2007, Idiopathic hypersomnia: a study of 77 cases, Sleep, 30, 1274, 10.1093/sleep/30.10.1274 Bassetti, 1997, Idiopathic hypersomnia. A series of 42 patients, Brain, 120, 1423, 10.1093/brain/120.8.1423 Pizza, 2011, Different sleep onset criteria at the multiple sleep latency test (MSLT): an additional marker to differentiate central nervous system (CNS) hypersomnias, J Sleep Res, 20, 250, 10.1111/j.1365-2869.2009.00808.x Zhang, 2018, Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning, Sci Rep, 8 Murer, 2017, Optimizing MSLT specificity in narcolepsy with cataplexy, Sleep, 40, zsx173, 10.1093/sleep/zsx173 Pizza, 2013, Polysomnographic study of nocturnal sleep in idiopathic hypersomnia without long sleep time, J Sleep Res, 22, 185, 10.1111/j.1365-2869.2012.01061.x Cook, 2019, Optimizing actigraphic estimation of sleep duration in suspected idiopathic hypersomnia, J Clin Sleep Med, 15, 597, 10.5664/jcsm.7722 Leu-Semenescu, 2017, French consensus. Idiopathic hypersomnia: investigations and follow-up, Rev Neurol (Paris), 173, 32, 10.1016/j.neurol.2016.09.015 Plante, 2015, Hypersomnia in mood disorders: a rapidly changing landscape, Curr Sleep Med Rep, 1, 122, 10.1007/s40675-015-0017-9 Lopez, 2013, Functional impairment in adult sleepwalkers: a case-control study, Sleep, 36, 345, 10.5665/sleep.2446 Lopez, 2014, Objective daytime sleepiness in patients with somnambulism or sleep terrors, Neurology, 83, 2070, 10.1212/WNL.0000000000001019 Carrillo-Solano, 2016, Sleepiness in sleepwalking and sleep terrors: a higher sleep pressure?, Sleep Med, 26, 54, 10.1016/j.sleep.2015.11.020 Leu-Semenescu, 2022, Comorbid parasomnias in narcolepsy and idiopathic hypersomnia: more REM than NREM parasomnias, J Clin Sleep Med, 18, 1355, 10.5664/jcsm.9862 Gasa, 2013, Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure, J Sleep Res, 22, 389, 10.1111/jsr.12039 Pepin, 2009, Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study, Eur Respir J, 33, 1062, 10.1183/09031936.00016808 Vgontzas, 1998, Obesity without sleep apnea is associated with daytime sleepiness, Arch Intern Med, 158, 1333, 10.1001/archinte.158.12.1333 Panossian, 2012, Daytime sleepiness in obesity: mechanisms beyond obstructive sleep apnea—a review, Sleep, 35, 605, 10.5665/sleep.1812 Dauvilliers, 2009, Psychological health in central hypersomnias: the French Harmony study, J Neurol Neurosurg Psychiatry, 80, 636, 10.1136/jnnp.2008.161588 Ozaki, 2008, Health-related quality of life among drug-naive patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time, J Clin Sleep Med, 4, 572, 10.5664/jcsm.27352 Kanbayashi, 2009, CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome, Sleep, 32, 181, 10.1093/sleep/32.2.181 Andlauer, 2012, Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy, Sleep, 35, 1247, 10.5665/sleep.2080 Mignot, 1997, HLA DQB1∗0602 is associated with cataplexy in 509 narcoleptic patients, Sleep, 20, 1012 Ali, 2009, Idiopathic hypersomnia: clinical features and response to treatment, J Clin Sleep Med, 5, 562, 10.5664/jcsm.27658 Pizza, 2020, Excessive daytime sleepiness in narcolepsy and central nervous system hypersomnias, Sleep Breath, 24, 605, 10.1007/s11325-019-01867-7 Bušková, 2022, Self-reported symptoms and objective measures in idiopathic hypersomnia and hypersomnia associated with psychiatric disorders: a prospective cross-sectional study, J Clin Sleep Med, 18, 713, 10.5664/jcsm.9702 Saad, 2021 2013, DSM-5 Baldwin, 2006, Symptoms of fatigue and sleepiness in major depressive disorder, J Clin Psychiatr, 67, 9 Plante, 2016, Subjective and objective measures of hypersomnolence demonstrate divergent associations with depression among participants in the Wisconsin Sleep Cohort Study, J Clin Sleep Med, 12, 571, 10.5664/jcsm.5694 Arand, 2019, The multiple sleep latency test, Handb Clin Neurol, 160, 393, 10.1016/B978-0-444-64032-1.00026-6 Kolla, 2020, Advance taper of antidepressants prior to multiple sleep latency testing increases the number of sleep-onset rapid eye movement periods and reduces mean sleep latency, J Clin Sleep Med, 16, 1921, 10.5664/jcsm.8738 Mansukhani, 2021, The influence of antidepressants and actigraphy-derived sleep characteristics on pediatric multiple sleep latency testing, J Clin Sleep Med, 17, 2179, 10.5664/jcsm.9338 Galušková, 2021, Idiopathic hypersomnia and depression, the challenge for clinicians and researchers, Prague Med Rep, 122, 127, 10.14712/23362936.2021.13 Pagel, 2017, Drug-induced hypersomnolence, Sleep Med Clin, 12, 383, 10.1016/j.jsmc.2017.03.011 Mignot, 2002, The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias, Arch Neurol, 59, 1553, 10.1001/archneur.59.10.1553 Kanbayashi, 2002, CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia, J Sleep Res, 11, 91, 10.1046/j.1365-2869.2002.00284.x Dauvilliers, 2003, CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions, J Neurol Neurosurg Psychiatry, 74, 1667, 10.1136/jnnp.74.12.1667 Dauvilliers, 2012, Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions, Sleep, 35, 1359, 10.5665/sleep.2114 Ebrahim, 2003, Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia, J Neurol Neurosurg Psychiatry, 74, 127, 10.1136/jnnp.74.1.127 Barateau, 2021, Cerebrospinal fluid monoamine levels in central disorders of hypersomnolence, Sleep, 44, zsab012, 10.1093/sleep/zsab012 Rye, 2012, Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors, Sci Transl Med, 4, 161ra51, 10.1126/scitranslmed.3004685 Trotti, 2016, Flumazenil for the treatment of refractory hypersomnolence: clinical experience with 153 patients, J Clin Sleep Med, 12, 1389, 10.5664/jcsm.6196 Dauvilliers, 2016, Absence of gamma-aminobutyric acid-a receptor potentiation in central hypersomnolence disorders, Ann Neurol, 80, 259, 10.1002/ana.24710 Landzberg, 2019, Is idiopathic hypersomnia a circadian rhythm disorder?, Curr Sleep Med Rep, 5, 201, 10.1007/s40675-019-00154-x Lippert, 2014, Altered dynamics in the circadian oscillation of clock genes in dermal fibroblasts of patients suffering from idiopathic hypersomnia, PLoS One, 9, 10.1371/journal.pone.0085255 Materna, 2018, Idiopathic hypersomnia patients revealed longer circadian period length in peripheral skin fibroblasts, Front Neurol, 9, 424, 10.3389/fneur.2018.00424 Thomas, 2020, A circadian mechanism for idiopathic hypersomnia—a long biological night, Sleep Med, 74, 31, 10.1016/j.sleep.2020.07.023 Dauvilliers, 2017, Idiopathic hypersomnia, 883 Dauvilliers, 2017, [18F]Fludeoxyglucose-positron emission tomography evidence for cerebral hypermetabolism in the awake state in narcolepsy and idiopathic hypersomnia, Front Neurol, 8, 350, 10.3389/fneur.2017.00350 Boucetta, 2017, Altered regional cerebral blood flow in idiopathic hypersomnia, Sleep, 40, zsx140, 10.1093/sleep/zsx140 Trotti, 2021, Regional brain metabolism differs between narcolepsy type 1 and idiopathic hypersomnia, Sleep, 44, zsab050, 10.1093/sleep/zsab050 Plante, 2018, Nocturnal sleep architecture in idiopathic hypersomnia: a systematic review and meta-analysis, Sleep Med, 45, 17, 10.1016/j.sleep.2017.10.005 Maski, 2021, Stability of nocturnal wake and sleep stages defines CNS disorders of hypersomnolence, Sleep, 44, zsab021, 10.1093/sleep/zsab021 Cairns, 2019, Comparison of the macro and microstructure of sleep in a sample of sleep clinic hypersomnia cases, Neurobiol Sleep Circadian Rhythms, 6, 62, 10.1016/j.nbscr.2019.02.001 2021 Dauvilliers, 2022, Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study, Lancet Neurol, 21, 53, 10.1016/S1474-4422(21)00368-9 Evangelista, 2018, Update on treatment for idiopathic hypersomnia, Expet Opin Invest Drugs, 27, 187, 10.1080/13543784.2018.1417385 Mayer, 2015, Modafinil in the treatment of idiopathic hypersomnia without long sleep time—a randomized, double-blind, placebo-controlled study, J Sleep Res, 24, 74, 10.1111/jsr.12201 Inoue, 2021, Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study, Sleep Med, 80, 315, 10.1016/j.sleep.2021.01.018 Trotti, 2014, Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: clinical experience, J Psychopharmacol, 28, 697, 10.1177/0269881113515062 Trotti, 2015, Clarithromycin in γ-aminobutyric acid-related hypersomnolence: a randomized, crossover trial, Ann Neurol, 78, 454, 10.1002/ana.24459 Leu-Semenescu, 2014, Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review, Sleep Med, 15, 681, 10.1016/j.sleep.2014.01.021 Gool, 2022, Data-driven phenotyping of central disorders of hypersomnolence with unsupervised clustering, Neurology, 98, e2387, 10.1212/WNL.0000000000200519 Barateau, 2022, Changes in sleep pattern during the COVID-19 lockdown in patients with narcolepsy, idiopathic hypersomnia, and restless legs syndrome, Neurology, 99, e1475, 10.1212/WNL.0000000000200907 Nigam, 2022, Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia, J Clin Sleep Med, 18, 255, 10.5664/jcsm.9556 Johns, 1991, A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale, Sleep, 14, 540, 10.1093/sleep/14.6.540 Bassetti, 2003, The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A), Sleep Med, 4, 7, 10.1016/s1389-9457(02)00191-0